1. Home
  2. EVTV vs IMNN Comparison

EVTV vs IMNN Comparison

Compare EVTV & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$1.53

Market Cap

11.5M

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$3.22

Market Cap

12.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTV
IMNN
Founded
2012
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
12.5M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
EVTV
IMNN
Price
$1.53
$3.22
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$182.61
AVG Volume (30 Days)
1.5M
31.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.00
EPS
N/A
N/A
Revenue
$1,870,060.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.37
52 Week High
$5.07
$9.32

Technical Indicators

Market Signals
Indicator
EVTV
IMNN
Relative Strength Index (RSI) 39.57 48.98
Support Level $0.19 $3.01
Resistance Level $1.69 $4.26
Average True Range (ATR) 0.18 0.21
MACD -0.07 0.02
Stochastic Oscillator 12.76 45.28

Price Performance

Historical Comparison
EVTV
IMNN

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: